VivoSim Labs (VIVS) Non Operating Interest Expenses (2011 - 2026)
VivoSim Labs (VIVS) posted Non Operating Interest Expenses of $4000.0 for Q2 2026, little changed on a QoQ basis from $4000.0 in Q1 2026, and little changed year-over-year from $4000.0 in Q2 2025.
Powered by 
Analysis
VivoSim Labs (VIVS) Non Operating Interest Expenses (2011 - 2026) Analysis & Trends
VivoSim Labs has reported Non Operating Interest Expenses for 7 years, with the latest figure at $4000.0 in Q2 2026.
- On a quarterly basis, Non Operating Interest Expenses changed 0.0% year-over-year to $4000.0 in Q2 2026; TTM through Jun 2026 was $12000.0, a 14.29% decrease from a year earlier, with the FY2026 full-year figure at $12000.0, up 20.0% from the prior year.
- Non Operating Interest Expenses was $4000.0 for Q2 2026 at VivoSim Labs, roughly flat from $4000.0 in the prior quarter.
- The five-year high for Non Operating Interest Expenses was $5000.0 in Q4 2024, with the low at $4000.0 in Q2 2025.
- Average Non Operating Interest Expenses over 3 years is $4333.3, with a median of $4000.0 recorded in 2025.
- The sharpest annual moves came in 2025 and 2026: Non Operating Interest Expenses fell 20.0% in 2025, then changed 0.0% in 2026.
- Over 3 years, Non Operating Interest Expenses stood at $5000.0 in 2024, then declined by 20.0% to $4000.0 in 2025, then changed by 0.0% to $4000.0 in 2026.
- The last three Non Operating Interest Expenses figures came in at $4000.0 (Q2 2026), $4000.0 (Q1 2026), and $4000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 197.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | - |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 30.34 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | -48.79 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | -3,647.53 |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | 4,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,000.00 |
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Jun 30, 2015 | 3,000.00 |
| Sep 30, 2013 | 13,000.00 |
| Jun 30, 2013 | 13,000.00 |
| Dec 31, 2012 | 344.00 |
| Sep 30, 2012 | 596.00 |
| Jun 30, 2012 | -547.00 |
| Mar 31, 2012 | 1.09 Mn |
| Dec 31, 2011 | 1.77 Mn |
| Sep 30, 2011 | 182,320.00 |
| Jun 30, 2011 | 58,843.00 |
| Mar 31, 2011 | 53,082.00 |